中医药治疗痰浊血瘀型冠心病心绞痛的研究进展

Research Progress on Traditional Chinese Medicine in Treating Coronary Heart Disease Angina Pectoris of Phlegm-Turbidity and Blood-Stasis Type

摘要: 冠心病心绞痛的发病率与死亡率逐年增长，是最常见的心血管系统疾病，在中医学中病属“胸痹”，临床以痰浊血瘀证最为多见，病机复杂。现代医学治疗方案虽明确，但长期应用副作用较多。中医药以辨证施治为核心，具有疗效显著、安全性高等特点。本文通过归纳整理近年来相关论述及研究，对痰浊血瘀型冠心病心绞痛的病因病机及其治疗进展进行综述，以期为临床提供参考。

Abstract: Coronary heart disease with angina pectoris, known as “chest pain and stuffiness” in traditional Chinese medicine, has seen a year-by-year increase in both incidence and mortality rates, making it the most common cardiovascular disorder. Clinically, the phlegm-turbidity and blood-stasis syndrome is the most prevalent pattern, characterized by complex pathogenesis. Although modern medical treatments offer clear therapeutic protocols, long-term application often leads to significant side effects. Traditional Chinese medicine, centered on treatment based on syndrome differentiation, demonstrates notable therapeutic efficacy and high safety profiles. This paper reviews recent relevant discussions and research on the etiology, pathogenesis, and treatment advances of coronary heart disease with angina pectoris of the phlegm-turbidity and blood-stasis type, aiming to provide clinical reference.